You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Treatment-related AML

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patterns and Key Healthcare Resource Use in Acute Myeloid

Completed
  • Acute Myeloid Leukemia (AML)
  • Treatment patterns among AML patients
  • AML-related healthcare resources
  • Charlotte, North Carolina
    Sermo
Jan 25, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Biospecimen Collection
  • +3 more
  • Baltimore, Maryland
  • +2 more
Jan 19, 2023

iN the Real Practice

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Vyxeos liposomal
  • Roma, Italy
    Policlinico Tor Vergata
Nov 16, 2023

Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone

Withdrawn
  • Drug/Agent Toxicity by Tissue/Organ
  • +3 more
  • amifostine trihydrate
  • +2 more
  • Chicago, Illinois
  • +3 more
Jan 31, 2023

Core Binding Factor Acute Myeloid Leukemia, KIT Mutation-Related Tumors Trial in Suzhou (Avapritinib)

Recruiting
  • Core Binding Factor Acute Myeloid Leukemia
  • KIT Mutation-Related Tumors
  • Suzhou, Jiangsu, China
    First Affiliated Hospital of Soochow University
Apr 7, 2023

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Blasts Under

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +3 more
  • Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 10, 2022

Bortezomib, Acute Myeloid Leukemia Trial in Wuhan (DAG pre-excitation regimen with Bortezomib)

Recruiting
  • Bortezomib
  • Acute Myeloid Leukemia
  • DAG pre-excitation regimen with Bortezomib
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jul 31, 2023

Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Boston, Massachusetts
  • +1 more
Mar 31, 2023

Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

Not yet recruiting
  • Acute Myeloid Leukemia
    • (no location specified)
    Sep 22, 2023

    Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

    Recruiting
    • Acute Bilineal Leukemia
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 24, 2023

    Acute Myelogenous Leukemia (AML) Due to Therapy, Acute Myeloid Leukemia With Myelodysplasia-Related Changes Trial in La Jolla,

    Recruiting
    • Acute Myelogenous Leukemia (AML) Due to Therapy
    • Acute Myeloid Leukemia With Myelodysplasia-Related Changes
    • Orange, California
    • +2 more
    Nov 30, 2022

    AML Trial in Berne (Image-based ex-vivo drug screening platform (pharmacoscopy))

    Recruiting
    • AML
    • Image-based ex-vivo drug screening platform (pharmacoscopy)
    • Berne, Switzerland
      Departement of Medical Oncology, University Hospital Berne
    Feb 8, 2023

    Newly-diagnosed APL (de Novo or Therapy-related), Relapsed APL Trial in Dresden (observational)

    Recruiting
    • Newly-diagnosed APL (de Novo or Therapy-related)
    • Relapsed APL
    • observational
    • Dresden, Germany
      Prof. Dr. U. Platzbecker
    Aug 10, 2022

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia Arising

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • (no location specified)
    Nov 8, 2022

    AML, Adult Trial in Netherlands (azacitidine, Venetoclax, Cobicistat)

    Not yet recruiting
    • AML, Adult
    • Amersfoort, Netherlands
    • +17 more
    Aug 23, 2023

    AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)

    Not yet recruiting
    • AML, Adult
    • +4 more
    • Amiens, France
    • +19 more
    Sep 1, 2023

    Acute Myeloid Leukemia in Remission, FLT3 Gene Mutation, Hematologic and Lymphocytic Disorder Trial in Houston (Azacitidine,

    Recruiting
    • Acute Myeloid Leukemia in Remission
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 13, 2022

    Leukemia, Myeloid, Acute Trial in Poznan (Liposomal Annamycin, Cytarabine)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Bologna, Italy
    • +4 more
    Jan 31, 2023

    Acute Myeloid Leukemia, MDS, Transplant-Related Hematologic Malignancy Trial in Milano (Fludarabine, ARA-C, Treosulfan)

    Completed
    • Acute Myeloid Leukemia
    • +2 more
    • Milano, Lombardia, Italy
      Ospedale San Raffaele
    Jul 18, 2022

    Acute Myeloid Leukemia Trial in Beijing, Shenzhen, Haikou (CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells)

    Recruiting
    • Acute Myeloid Leukemia
    • CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells
    • Beijing, Beijing, China
    • +2 more
    Aug 8, 2023

    Acute Myeloid Leukemia Trial (Sulfasalazine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Oct 11, 2022

    Acute Myeloid Leukemia Trial in Germany (Venetoclax plus Azacitidine, standard of care chemo plus gemtuzumab ozogamicin)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Venetoclax plus Azacitidine
    • standard of care chemotherapy plus gemtuzumab ozogamicin
    • Essen, NRW, Germany
    • +17 more
    Jun 6, 2023

    UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Wuhan (Basic

    Recruiting
    • UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
    • Basic chemotherapy + UCB transplantation
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Oct 9, 2022

    AML, MDS Trial in Tianjin (XZB-0004)

    Not yet recruiting
    • AML
    • MDS
    • Tianjin, Tianjin, China
      Hematology Hospital, Chinese Academy of Medical Sciences
    Feb 13, 2023

    Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)

    Active, not recruiting
    • Relapsed Adult ALL
    • Relapsed Adult AML
    • Changchun, Jilin, China
      First Hospital of Jilin University
    Nov 19, 2023